In summary, for the first time, B2-CIC (IgG and IgM) has been described and its presence has been associated with clinical manifestations related to APS as thrombocytopenia, LR, sicca ophthalmic, and leukopenia as well as higher complement consumption. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.